Q4 2025 Management View CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent ...

BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...

Please provide your email address to receive an email when new articles are posted on . The Clareon family of IOLs is now available in the U.S., with an international rollout set to take place ...

Alcon noted that Clareon offers a sharp, crisp vision with a proprietary edge designed to help reduce glare and posterior capsular opacification. Its STABLEFORCE Haptics provides superior axial and ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

Data around recently launched Clareon® IOL material showcases excellent vision and lasting clarity—three years after implantation1 ARGOS® Biometer with Image Guidance demonstrates significant time ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...

TORONTO, Feb. 1, 2021 /CNW/ - Alcon, the global leader in eye care, is pleased to announce a nationwide launch of the Clareon ® intraocular lens (IOL) with the AutonoMe ® delivery system in Canada.

Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...